Last reviewed · How we verify
NCT07101133
Precision Nutrition Technologies for Obesity Management
NA trial testing Control group: Energy-limited balanced diet group in Obesity and Obesity-related Medical Conditions in 600 participants. Not yet recruiting.
30 June 2026
Quick facts
| Lead sponsor | Yuan He |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | health services research |
| Enrollment | 600 |
| Start date | 27 July 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 June 2027 |
Drugs / interventions tested
- Control group: Energy-limited balanced diet group
Conditions studied
- Obesity and Obesity-related Medical Conditions — all drugs for Obesity and Obesity-related Medical Conditions →
Sponsor
Yuan He
Who can join
Adults 18 to 60, any sex, with Obesity and Obesity-related Medical Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The implementation of this project will develop and apply precision health dietary solutions tailored for weight management in China's obese population, establishing a precision nutrition intervention model. Over 50% of the obese individuals are expected to achieve a weight reduction of more than 5%, significantly improving their quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07101133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity and Obesity-related Medical Conditions
Currently open trials in the same condition.
- NCT06924177 — UTSW NORC Pilot Spinal Cord Injury Dietary Program · NA · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
- NCT07213245 — Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF) · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
- NCT06790225 — Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07101133 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yuan He
- Last refreshed: 3 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07101133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing